logo
  • About Us
    • Management Team
  • Pipeline
    • CAR T-cell therapies
    • mAb
  • Technology/Platform
    • Technology/Platform
    • Manufacturing
    • Publication
    • Expanded Access
  • Media
  • Join Us
  • Investors
    • Announcements
    • Corporate Governance
    • Listing Documents
    • Financial Reports
    • Presentations & Webcasts
      • Webcasts
      • Presentations
    • IR Contact
  • Contact Us
EN 简 繁
EN 简 繁
EN 简 繁
  • About Us
    • Management Team
  • Pipeline
    • CAR T-cell therapies
    • mAb
  • Technology/Platform
    • Technology/Platform
    • Manufacturing
    • Publication
    • Expanded Access
  • Media
  • Join Us
  • Investors
    • Announcements
    • Corporate Governance
    • Listing Documents
    • Financial Reports
    • Presentations & Webcasts
      • Webcasts
      • Presentations
    • IR Contact
  • Contact Us

Presentations & Webcasts

  • Announcements
  • Corporate Governance
  • Listing Documents
  • Financial Reports
  • Presentations & Webcasts
  • IR Contact
Webcasts
Presentations
iconDate Date
iconTitle Title
Jun 05, 2022
2022 ASCO | Safety, Tolerability and Preliminary Efficacy Results in Patients with Advanced Gastric/Gastroesophageal Junction Adenocarcinoma from a Phase Ib/II Study of CLDN18.2 CAR T‐cell therapy (CT041)
Jun 05, 2022
2022 ASCO | Multicenter Phase 1b Trial of Salvage CT041 CLDN18.2-specific Chimeric Antigen Receptor T Cell Therapy for Patients with Advanced Gastric and Pancreatic Adenocarcinoma
Dec 13, 2021
2021 ASH | Sustainable Efficacy and Safety Results from LUMMICAR STUDY 1: A Phase 1/2 Study of Fully Human B-Cell Maturation Antigen-Specific CAR T Cells (CT053) in Chinese Subjects with Relapsed and/or Refractory Multiple Myeloma
Dec 13, 2021
2021 ASH | Integrated Analysis of B-cell Maturation Antigen-Specific CAR T Cells (CT053) in Relapsed and Refractory Multiple Myeloma Subjects by High-Risk Factors
Sep 19, 2021
2021 ESMO | CLDN 18.2-targeted CAR-T cell therapy (CT041) in patients with cancers of the digestive system
  • 1
Read Us/Contact Us
  • About Us
  • Management Team
  • Pipeline
  • CAR T-cell therapies
  • mAb
  • Technology/Platform
  • Technology/Platform
  • Manufacturing
  • Publication
  • Expanded Access
  • Join Us
  • Investors
  • Announcements
  • Corporate Governance
  • Listing Documents
  • Financial Reports
  • Presentations & Webcasts
  • IR Contact
  • Media
  • Contact Us
Copyright ©2021 CARsgenTherapeutics Co.,Ltd!
Privacy Policy Terms of Use Developed by Euroland IR